UK Markets close in 6 hrs 16 mins

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
203.90+10.64 (+5.51%)
At close: 04:00PM EDT
202.08 -1.82 (-0.89%)
After hours: 07:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3279.02
52-week low 3164.47
50-day moving average 3206.55
200-day moving average 3222.85

Share statistics

Avg vol (3-month) 31.45M
Avg vol (10-day) 31.38M
Shares outstanding 5311.02M
Implied shares outstanding 6N/A
Float 8223.19M
% held by insiders 124.35%
% held by institutions 168.55%
Shares short (14 Jul 2022) 44.57M
Short ratio (14 Jul 2022) 42.03
Short % of float (14 Jul 2022) 42.04%
Short % of shares outstanding (14 Jul 2022) 41.55%
Shares short (prior month 14 Jun 2022) 45.06M

Dividends & splits

Forward annual dividend rate 42.24
Forward annual dividend yield 41.05%
Trailing annual dividend rate 30.48
Trailing annual dividend yield 30.25%
5-year average dividend yield 4N/A
Payout ratio 410.04%
Dividend date 329 Sept 2022
Ex-dividend date 414 Sept 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 10.83%
Operating margin (ttm)15.57%

Management effectiveness

Return on assets (ttm)11.73%
Return on equity (ttm)2,259.57%

Income statement

Revenue (ttm)60.1B
Revenue per share (ttm)196.94
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)22.49B
EBITDA 12.27B
Net income avi to common (ttm)6.51B
Diluted EPS (ttm)13.38
Quarterly earnings growth (yoy)-20.30%

Balance sheet

Total cash (mrq)858M
Total cash per share (mrq)2.9
Total debt (mrq)40.7B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.55
Book value per share (mrq)0.74

Cash flow statement

Operating cash flow (ttm)7.7B
Levered free cash flow (ttm)2.68B